Fred Saad

85PUBLICATIONS
243CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (85)

|May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.

|May 07, 2026
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

|Mar 28, 2026
Cancer-Specific Mortality in Sarcomatoid Renal Cell Carcinoma: A Histological Subtype-Controlled Analysis.

Michele Nicolazzini, Calogero Catanzaro, Federico Polverino

|Mar 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.

Andrew J Armstrong, Arun A Azad, Taro Iguchi

|Mar 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.

Karen Gambaro, Kahina Rachedi, Mark Basik

|Mar 07, 2026
Response to comments on 'Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy'.

Andrea Marmiroli, Francesco Di Bello, Natali Rodriguez Peñaranda

Pageof 15

Frequent Collaborators

11 joint publications

Francesco Di Bello

10 joint publications

Derya Tilki

8 joint publications

Anne-Marie Mes-Masson

7 joint publications

Letizia Maria Ippolita Jannello